<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Serum ferritin concentration was studied in 79 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> granulocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGL</z:e>), 14 patients with <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>), eleven patients with <z:e sem="disease" ids="C0238293" disease_type="Disease or Syndrome" abbrv="">osteomyelosclerosis</z:e> (OMS) and four patients with <z:e sem="disease" ids="C0023462" disease_type="Neoplastic Process" abbrv="">megakaryocytic myelosis</z:e> (MM) </plain></SENT>
<SENT sid="1" pm="."><plain>Pretreatment serum ferritin concentrations were found to be <z:mpath ids='MPATH_458'>normal</z:mpath> or slightly decreased in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>, OMS, MM and in the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGL</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Patients entering the blastic crisis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGL</z:e> had highly <z:hpo ids='HP_0003281'>increased serum ferritin</z:hpo> concentrations </plain></SENT>
<SENT sid="3" pm="."><plain>The severity of hyperferritinemia in these patients depended on the cytomorphological type of the blastic crisis </plain></SENT>
<SENT sid="4" pm="."><plain>Highest levels of serum ferritin concentration were found in the immature myeloblastic type according to the M1- and M2-type of the FAB-classification of <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> (i.e. 30-fold and 18-fold increased) </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, the rise of the serum ferritin concentration in the more mature types of blastic crisis was less pronounced (i.e. nine-fold in the M3-type and six-fold in the M4- and M5-type of blastic crisis) </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with complete remission after bone marrow transplantation had <z:mpath ids='MPATH_458'>normal</z:mpath> serum ferritin concentrations </plain></SENT>
<SENT sid="7" pm="."><plain>Investigation of the intracellular ferritin concentration showed, that the serum ferritin levels paralleled the intracellular ferritin concentration within the leukemic blasts: During the myeloic blastic crisis the intracellular ferritin concentration was found to be 17-fold increased compared to the intracellular ferritin concentrations in the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGL</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, our data support the concept that an increased synthesis of ferritin by the leukemic blasts is responsible for the <z:hpo ids='HP_0003281'>increased serum ferritin</z:hpo> concentration during the blastic crisis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGL</z:e>.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>